YourHealthRx

YourHealthRx review

Published prepaid supply totals with an expired rate-lock promotion. The costs, commitments and questions worth considering.

GLP1 Rank is a commercial comparison site. We may earn a commission through links. How we’re funded

Our take

I would compare YourHealthRx for someone comfortable with a longer supply purchase who values seeing the full amount rather than only an equivalent rate. My caution is the retained expired promotion and the need for a more explicit product-specific exit policy.

Reasons to look closer

  • Three- and six-month supply totals displayed
  • Platform and clinical intake roles distinguished
  • Product-specific availability explained separately from consultation coverage

Keep in mind

Injectable semaglutide shows $450 upfront for three months or $840 for six; ODT shows $540 or $1,020. Monthly rate-lock code is marked redeem by October15,2026 and is not treated as a current offer. Confirm ongoing prices and refund terms.

The costs at a glance

Published price reference$450/3-month supply
Compounded semaglutide injectable three-month purchase; $150/month equivalent
MedicationCompounded semaglutide injection or ODT; separate tirzepatide and other compounds
CommitmentThree- and six-month supply totals collected upfront; separate recurring monthly promotion has passed its stated redemption deadline
Important contextInjectable semaglutide shows $450 upfront for three months or $840 for six; ODT shows $540 or $1,020. Monthly rate-lock code is marked redeem by October15,2026 and is not treated as a current offer. Confirm ongoing prices and refund terms.

The prepaid totals are more useful than the lowest equivalent

YourHealthRx presents itself as an access and education platform connecting readers with independent clinicians and pharmacy partners. Its semaglutide page is useful because it distinguishes injectable and oral dissolving preparations and gives complete prices for longer supply purchases. I would begin with those totals rather than a headline monthly rate. The site also retains a rate-lock promotion with a stated redemption deadline that has already passed, so it is important to separate currently displayed plan information from a promotion a new reader may no longer qualify to use. My comparison would focus on the written offer available today and the ongoing clinical relationship.

The injection and ODT have different upfront amounts

The semaglutide page shows the injectable option at $450 upfront for three months, equivalent to $150 per month, and $840 for six months, equivalent to $140. The oral dissolving tablet is listed at $540 for three months and $1,020 for six, or $180 and $170 per month respectively. Those are full supply-purchase totals, not proof of flexible monthly billing. I would confirm how medication is dispensed across the term and whether the advertised quantity fits the clinician's prescription. If the plan changes, the handling of medication not yet prepared is as important as the original discount from purchasing a longer supply. For a closer comparison, see our total GLP-1 cost guide and apply those distinctions to the specific offer you receive.

Do not rely on the expired rate-lock code

The same page describes a monthly rate-lock code that had to be redeemed by October 15, 2026. I would not present that as an offer a new reader can currently obtain merely because the text remains visible. Existing continuously enrolled customers may have separate rights under their original terms, but that does not establish availability to someone joining now. Ask support for the current monthly option and regular renewal price. A reader comparing longer prepaid supplies should keep those verified totals separate from any expired promotion. The distinction avoids converting a retained marketing panel into an assumed permanent price guarantee.

The routing form is different from the medical intake

YourHealthRx's terms say its prequalification form collects routing information and should not receive detailed medical history, medication lists, laboratory results or other sensitive clinical material. The clinical information is collected through partner workflows. I would follow that distinction and make sure the independent practice is identified before submitting health records. The platform itself does not diagnose, prescribe or dispense medication. That separation can be sensible, but the reader should know which organization holds the records, makes the treatment decision and handles follow-up. A general eligibility form is not a clinician-patient relationship and should not be mistaken for a completed medical assessment. For a closer comparison, see our telehealth appointment checklist and apply those distinctions to the specific offer you receive.

The delivery format needs an evidence-based discussion

YourHealthRx lists a compounded weekly injection and an oral dissolving semaglutide tablet. I would ask the clinician why the actual preparation is being selected and what evidence applies to it, rather than treat both formats as interchangeable versions of a brand. The site discloses that compounded products are not FDA approved. An active ingredient shared with an approved medicine does not settle absorption, dosing or expected outcomes for a different preparation. Confirm the pharmacy, prescribed concentration and instructions before medication is prepared. The broader peptide catalog should remain separate from this decision; each additional treatment would need its own evidence, clinical rationale and price. For a closer comparison, see our oral GLP-1 versus compounded drops explanation and apply those distinctions to the specific offer you receive.

Consultation coverage and pharmacy delivery are different maps

The availability page describes telemedicine across the fifty states while distinguishing product-specific dispensing. It excludes the District of Columbia from pharmacy fulfillment and says some injectables have California restrictions. Its detailed table places compounded GLP-1 injectables in a different coverage group from several other injections. I would confirm the actual prescribed product rather than apply one broad California statement to the entire menu. The useful question is whether both the clinician and pharmacy can serve the reader's current location. If moving during a prepaid supply term, ask what happens to follow-up and remaining orders before purchasing the longer package.

The full care scope and refund rules still need confirmation

The site says its subscription pricing covers clinical access, coordination and the prescription when issued, with no separate standard shipping or clinician-review fee unless noted. That is a useful scope statement, but I would ask whether laboratory work, extra visits or a change in formulation can create additional charges. A longer purchase also needs a clear cancellation and refund policy for medication not yet dispensed. The accessible terms focus on platform use and do not by themselves settle the financial consequences of stopping a three- or six-month plan. I would obtain that answer in writing instead of assume that a prepaid supply is fully refundable or entirely non-refundable.

My take: compare the complete supply purchase, then verify the current offer

I would compare YourHealthRx for someone comfortable with a longer supply purchase who values seeing the full amount rather than only an equivalent rate. My caution is the retained expired promotion and the need for a more explicit product-specific exit policy. The three-month injection total is a clearer starting reference than assuming the lowest rate-lock figure remains available. Live Vital is useful to compare: compare a ten-week protocol as another defined supply commitment, using the complete payment and dispensing schedule. Oak offers a second reference: compare several treatment lengths without relying on an expired rate-lock promotion or assuming an equivalent rate is monthly billing.

Before you sign up

  • Which monthly offer is currently available after the rate-lock deadline?
  • How is the prepaid supply dispensed, and can unfilled portions be refunded?
  • Which clinician and pharmacy serve my product and location?

Use the answers to compare the exact offer with another provider. A service review cannot determine whether a medication is appropriate for you; that decision belongs with your clinician.

Compare the complete budget · Save your provider checklist

Research the questions behind this offer

Further reading

Other providers to compare

Compare a ten-week protocol as another defined supply commitment, using the complete payment and dispensing schedule.

Live Vital

Ten-week compounded treatment protocols

Live Vital

$299/10-week protocol

Advertised compounded semaglutide protocol

The page also says $99/month, but ten weeks is shorter than three calendar months. Renewal, dose-specific supply and extra charges need confirmation.

Compare several treatment lengths without relying on an expired rate-lock promotion or assuming an equivalent rate is monthly billing.

Oak

Online prescription care with several plan lengths

Oak

$119/month starting price

Advertised starting weight-loss program rate

The headline does not identify a universal medication, dose or term. Confirm the selected plan and renewal total before paying.

One more option